4.3 • 1.2K Ratings
🗓️ 11 November 2019
⏱️ 27 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | You're about to listen to a BBC podcast and trust me you'll get there in a moment but if you're a comedy fan |
0:05.2 | I'd really like to tell you a bit about what we do. I'm Julie Mackenzie and I commission comedy |
0:10.1 | podcast at the BBC. It's a bit of a dream job really. Comedy is a bit of a dream job really. |
0:13.0 | Comedy is a fantastic joyous thing to do because really you're making people laugh, |
0:18.0 | making people's days a bit better, helping them process, all manner of things. |
0:22.0 | But you know, I also know that comedy is really |
0:24.3 | subjective and everyone has different tastes. So we've got a huge range of comedy on offer from |
0:29.8 | satire to silly, shocking to soothing, profound to just general pratting about. |
0:35.0 | So if you fancy a laugh, find your next comedy at BBC Sounds. |
0:40.0 | This is Discovery from the BBC. I'm Jim El Killelli and in today's program I'm in conversation with a leading scientist about their life and research. Welcome to the life scientific. |
0:52.0 | So Greg Winter is a remarkable scientist. |
0:55.0 | Not only has he won a Nobel Prize for his biochemical research, |
0:58.0 | he's also pushed hard to maximize the benefit to humanity from his discoveries. |
1:03.2 | Humira is currently the best-selling drug in the world, used to treat a range of |
1:08.1 | autoimmune conditions like arthritis and Crohn's disease. |
1:12.4 | Thanks not only to his pioneering research, but arthritis and Crohn's disease. |
1:12.5 | Thanks not only to his pioneering research, |
1:14.7 | but also to his business sense and commitment to the public good, |
1:18.4 | his work has led to the rapid generation |
1:20.7 | of an entirely new class of therapeutic drugs known as monoclonal antibodies or |
1:26.1 | Mabs for short. Other well-known examples of Mab drugs include Herceptin for breast cancer and Avastin. In 2018 the market for these drugs was $70 billion. |
1:38.0 | In 1988 Greg engineered the first humanised monoclonal antibodies. Previous attempts to turn |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from BBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of BBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.